This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Cui S‐Z, Lei Z‐Y, Guan T–P, et al. Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy. Cancer Science. 2020; 111: 1567–1581. https://doi.org/10.1111/cas.14375
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUbiquitin and proteasome pathways · Peptidase Inhibition and Analysis · Advanced Proteomics Techniques and Applications
The above article, published online on 4 March 2020 on Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editor‐in‐Chief, Masanori Hatakeyama, the Japanese Cancer Association and John Wiley & Sons Australia, Ltd following concerns raised by a third party about figures within the article. During the journal's investigation into the concerns raised, the authors were not able to provide comprehensive original data for the relevant figures. Accordingly, the editors consider that the results in the published article are unreliable and do not sufficiently support the conclusions. The following authors of the article have stated that they were unaware of its publication: Shu‐Zhong Cui, Zi‐Ying Lei, Tian‐Pei Guan, Hao‐Wu Jiang.